POSITIVE ANTI-GP210 ANTIBODIES IS A STRONG RISK FACTOR FOR BILE DUCT LOSS AND HEPATITIS WHICH INDUCE JAUNDICE-TYPE PROGRESSION OF PRIMARY BILIARY CIRRHOSIS IN JAPANESE PATIENTS

被引:0
|
作者
Nakamura, M. [1 ,2 ]
Ito, M. [1 ]
Yamamoto, K. [3 ]
Zeniya, M. [4 ]
Ohira, H. [5 ]
Hashimoto, E. [6 ]
Kaneko, S. [7 ]
Ueno, Y. [8 ]
Kikuchi, K. [9 ]
Onji, M. [10 ]
Shimoda, S. [11 ]
Komori, A. [1 ]
Takikawa, H. [12 ]
Onishi, S. [13 ]
Tsubouchi, H. [14 ]
Ishibashi, H. [1 ,2 ]
Nakanuma, Y. [15 ]
机构
[1] Nagasaki Univ, Grad Sch Biomedial Sci, Clin Res Ctr, Nagasaki Med Ctr,Dept Hepatol, Omura, Japan
[2] Minist Hlth & Welf, Intractable Liver Dis Res Project Team, Headquaters Working Grp Gp210, Nagasaki, Japan
[3] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gastroenterol & Hepatol, Okayama 7008530, Japan
[4] Jikei Univ, Sch Med, Div Gastroenterol & Hepatol, Tokyo, Japan
[5] Fukushima Med Univ, Sch Med, Dept Internal Med 2, Fukushima, Japan
[6] Tokyo Womens Med Univ, Dept Med & Gastroenterol, Tokyo, Japan
[7] Kanazawa Univ, Grad Sch Med, Dept Gastroenterol, Kanazawa, Ishikawa, Japan
[8] Tohoku Univ, Grad Sch Med, Div Gastroenterol, Sendai, Miyagi 980, Japan
[9] Teikyo Univ, Mizokuchi Hosp, Dept Internal Med, Kawasaki, Kanagawa, Japan
[10] Ehime Univ, Grad Sch Med, Dept Gastroenterol & Metabol, Matsuyama, Ehime, Japan
[11] Kyushu Univ, Grad Sch Med Sci, Dept Med & Biosyst Sci, Fukuoka 812, Japan
[12] Teikyo Univ, Sch Med, Dept Med, Tokyo 173, Japan
[13] Kochi Med Sch, Dept Gastroenterol & Hepatol, Kochi, Japan
[14] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Digest & Life Style Related Dis, Kagoshima 890, Japan
[15] Kanazawa Univ, Grad Sch Med, Dept Human Pathol, Kanazawa, Ishikawa, Japan
关键词
D O I
10.1016/S0168-8278(10)61110-5
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:S428 / S429
页数:2
相关论文
共 9 条
  • [1] POSITIVE ANTI-GP210 ANTIBODIES IS A SIGNIFICANT RISK FACTOR FOR BILE DUCT LOSS, HEPATITIS AND POOR BIOCHEMICAL RESPONSE TO URSODEOXYCHOLIC ACID TREATMENT THAT LEAD TO MORE SEVERE PROGRESSION IN JAPANESE PATIENTS WITH PRIMARY BILIARY CIRRHOSIS
    Nakamura, Minoru
    Ito, Masahiro
    Kondo, Hisayoshi
    Yamamoto, Kazuhide
    Ohira, Hiromasa
    Zeniya, Mikio
    Tanaka, Atsushi
    Hashimoto, Etsuko
    Honda, Masao
    Kaneko, Shuichi
    Ueno, Yoshiyuki
    Kikuchi, Kentaro
    Shimoda, Shinji
    Komori, Atsumasa
    Harada, Kenichi
    Sakisaka, Shotaro
    Takikawa, Hajime
    Onji, Morikazu
    Onishi, Saburo
    Tsubouchi, Hirohito
    Nakanuma, Yasuni
    Ishibashi, Hiromi
    HEPATOLOGY, 2011, 54 : 1208A - 1209A
  • [2] POSITIVE ANTI-GP210 ANTIBODIES IS A RISK FACTOR FOR POOR BIOCHEMICAL RESPONSE TO URSODEOXYCHOLIC ACID TREATMENT IN JAPANESE PATIENTS WITH PRIMARY BILIARY CIRRHOSIS
    Nakamura, M.
    Ito, M.
    Yamamoto, K.
    Zeniya, M.
    Ohira, H.
    Hashimoto, E.
    Honda, M.
    Kaneko, S.
    Ueno, Y.
    Kikuchi, K.
    Onji, S.
    Shimoda, S.
    Takikawa, H.
    Tanaka, A.
    Komori, A.
    Yatsuhashi, H.
    Kondo, H.
    Harada, K.
    Onishi, S.
    Tsubouchi, H.
    Nakanuma, Y.
    Ishibashi, H.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S514 - S515
  • [3] Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis
    Nakamura, Minoru
    Kondo, Hisayoshi
    Mori, Tsuyoshi
    Komori, Atsumasa
    Matsuyama, Mutstuni
    Ito, Masahiro
    Takii, Yasushi
    Koyabu, Makiko
    Yokoyama, Terufumi
    Migita, Kiyoshi
    Daikoku, Manabu
    Abiru, Seigo
    Yatsuhashi, Hiroshi
    Takezaki, Eiichi
    Masaki, Naohiko
    Sugi, Kazuhiro
    Honda, Koichi
    Adachi, Hiroshi
    Nishi, Hidehiro
    Watanabe, Yukio
    Nakamura, Yoko
    Shimada, Masaaki
    Komatsu, Tatsuji
    Saito, Akira
    Saoshiro, Takeo
    Harada, Hideharu
    Sodeyama, Takeshi
    Hayashi, Shigeki
    Masumoto, Akihide
    Sando, Takehiro
    Yamamoto, Tetsuo
    Sakai, Hironori
    Kobayashi, Masakazu
    Muro, Toyokichi
    Koga, Michiaki
    Shums, Zakera
    Norman, Gary L.
    Ishibashi, Hiromi
    HEPATOLOGY, 2007, 45 (01) : 118 - 127
  • [4] Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis
    Nakamura, Minoru
    Kondo, Hisayoshi
    Mori, Tsuyoshi
    Komori, Atsumasa
    Matsuyama, Mutsumi
    Ito, Masahiro
    Daikoku, Manabu
    Yatsuhashi, Hiroshi
    Takezaki, Eiichi
    Masaki, Naohiko
    Sugi, Kazuhiro
    Adachi, Hiroshi
    Sakai, Norihiro
    Watanabe, Yukio
    Saoshiro, Takeo
    Honda, Koichi
    Harada, Hideharu
    Hayashi, Shigeki
    Sando, Takehiro
    Masumoto, Akihide
    Shimada, Masaaki
    Komatsu, Tatsuji
    Shums, Zakera
    Norman, Gary L.
    Ishibashi, Hiromi
    HEPATOLOGY, 2006, 44 (04) : 629A - 629A
  • [5] Kinetics of anti-gp210 antibodies in primary biliary cirrhosis patients with ursodesoxycholic acid therapy
    Boissan, M
    Ballot, E
    Johanet, C
    AUTOANTIGENS AND AUTOANTIBODIES: DIAGNOSTIC TOOLS AND CLUES TO UNDERSTANDING AUTOIMMUNITY, 2000, 1 : 507 - 508
  • [6] Presence of anti-gp210 or anti-sp100 antibodies in AMA-positive patients may help support a diagnosis of primary biliary cholangitis
    Jaskowski, Troy D.
    Nandakumar, Vijayalakshmi
    Novis, Camille L.
    Palmer, Michael
    Tebo, Anne E.
    CLINICA CHIMICA ACTA, 2023, 540
  • [7] ANTI-GP210-POSITIVE PATIENTS WITH PRIMARY BILIARY CHOLANGITIS FULFILLED RESPONSE CRITERIA BUT NOT ACHIEVED NORMAL LIVER FUNCTION MAY HAVE THE RISK OF DISEASE PROGRESSION
    Zhang, Xue
    Wang, Xiaoyi
    Yang, Hui
    Ji, Guixian
    Yang, Zhen
    Li, Jiwen
    Han, Zongze
    Zhang, Yujie
    Zhao, Jingwen
    Zhong, Weilong
    Li, Yanni
    Li, Long
    Ran, Ying
    Wang, Bangmao
    Lu, Zhou
    GASTROENTEROLOGY, 2023, 164 (06) : S1428 - S1428
  • [8] Genetic polymorphism of HLA-DR and cytokine genes in Japanese patients with primary biliary cirrhosis (PBC) - HLA-DRB1*0405 confers susceptibility to gp210-type progression of PBC
    Nakamura, Minoru
    Kondo, Hisayoshi
    Aiba, Yoshihiro
    Komori, Atsumasa
    Matsuyama, Mutsumi
    Ito, Masahiro
    Migita, Kiyoshi
    Yatsuhashi, Hiroshi
    Saoshiro, Takeo
    Koga, Michiaki
    Watanabe, Yukio
    Hayashi, Hideki
    Shimada, Masaaki
    Masaki, Naohiko
    Morimoto, Hideo
    Kobayashi, Masakazu
    Honda, Koichi
    Oishi, Hiroki
    Tsukamoto, Kazuhiro
    Kikuchi, Mihoko
    Yasunami, Michio
    Ishibashi, Hiromi
    HEPATOLOGY, 2007, 46 (04) : 544A - 545A
  • [9] ANALYSIS OF HLA-DRB1 POLYMORPHISM IN JAPANESE PATIENTS WITH PRIMARY BILIARY CIRRHOSIS(PBC) - HLA-DRB1 POLYMORPHISM DETERMINES THE RELATIVE RISK OF ANTI-NUCLEAR ANTIBODIES FOR THE DISEASE-PROGRESSION IN PBC
    Nakamura, Minoru
    Yasunami, Michio
    Kondo, Hisayoshi
    Aiba, Yoshihiro
    Komori, Atsumasa
    Migita, Kiyoshi
    Yatsuhashi, Hiroshi
    Nakamuta, Makoto
    Hayashi, Shigeki
    Saito, Akira
    Honda, Koichi
    Shimada, Masaaki
    Watanabe, Yukio
    Yagura, Michiyasu
    Kohno, Hiroshi
    Sugi, Kazuhiro
    Ota, Hajime
    Komatsu, Tatsushi
    Mannami, Tomohiko
    Koga, Michiaki
    Satoh, Takeaki
    Takesaki, Eiichi
    Yamamoto, Tetsuo
    Oohara, Yukio
    Masaki, Naohiko
    Ishibashi, Hiromi
    HEPATOLOGY, 2009, 50 (04) : 1004A - 1004A